Header graphic for print
Focus on Regulation

Tag Archives: National Development and Reform Commission

Antitrust in China’s pharma sector – Bengbu action following big-bang reform

On 26 August 2015, the National Development and Reform Commission (NDRC) made public its first antitrust enforcement decision in the pharmaceutical sector since launching the drug pricing reform earlier this year. Although the target of this enforcement action was a local government entity, pharmaceutical companies should expect continued antitrust intervention in parallel with the implementation

Record antitrust fines in China

The National Development and Reform Commission (“NDRC“) has started 2013 with a bang.  On 4 January 2013, it announced that it had imposed sanctions of close to USD 56 million on six liquid crystal display (“LCD“) makers from Korea and Taiwan, accusing the companies of illegal price-fixing.   These sanctions set an absolute record for antitrust